Skip to main content
Clinical Trials/ISRCTN14973494
ISRCTN14973494
Completed
未知

COVID anxiety: Risks, consequences and feasibility trial

Imperial College London0 sites40 target enrollmentSeptember 9, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental health issues due to COVID-19
Sponsor
Imperial College London
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36691181/ (added 24/01/2023) 2024 Results article in https://doi.org/10.1186/s12888-023-05446-9 (added 08/01/2024)

Registry
who.int
Start Date
September 9, 2021
End Date
May 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 or over
  • 2\. Score 9 or more on the Covid Anxiety Scale
  • Additionally for the nested feasibility trial
  • 3\. Score 20 or more on the Health Anxiety Inventory

Exclusion Criteria

  • 1\. A current or previous diagnosis of a psychotic mental disorder
  • Additionally for the nested feasibility trial
  • 2\. Has had COVID\-19 within the last 4 weeks (defined as a positive antigen test or a diagnosis from a clinician)
  • 3\. Has been told, either by a doctor or the NHS Test and Trace service, that they should self\-isolate due to the possibility that they have been exposed to covid\-19
  • 4\. Currently in receipt of a psychological treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials